| 000 | 01535 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516125319.0 | ||
| 264 | 0 | _c20130701 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1421-9794 | ||
| 024 | 7 |
_a10.1159/000343656 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrito, A F | |
| 245 | 0 | 0 |
_aHepatocellular carcinoma and chemotherapy: the role of p53. _h[electronic resource] |
| 260 |
_bChemotherapy _c2012 |
||
| 300 |
_a381-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCisplatin _xpharmacology |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 |
_aFluorouracil _xpharmacology |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 650 | 0 | 4 |
_abcl-2-Associated X Protein _xmetabolism |
| 700 | 1 | _aAbrantes, A M | |
| 700 | 1 | _aPinto-Costa, C | |
| 700 | 1 | _aGomes, A R | |
| 700 | 1 | _aMamede, A C | |
| 700 | 1 | _aCasalta-Lopes, J | |
| 700 | 1 | _aGonçalves, A C | |
| 700 | 1 | _aSarmento-Ribeiro, A B | |
| 700 | 1 | _aTralhão, J G | |
| 700 | 1 | _aBotelho, M F | |
| 773 | 0 |
_tChemotherapy _gvol. 58 _gno. 5 _gp. 381-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000343656 _zAvailable from publisher's website |
| 999 |
_c22362739 _d22362739 |
||